Client News
invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors
19th June 2023
Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023
15th June 2023
Digital health start-up Capreolos GmbH launches Ready4OP app to support patients before major surgical procedures
15th June 2023
Medigene AG: Medigene to Host Virtual R&D Event on TCR-T Therapies for Solid Tumors
13th June 2023
ITM Opens World’s Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer
13th June 2023
Biotalys announces closing of private placement
12th June 2023
Abivax stock included in MSCI indexes
8th June 2023
Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million
7th June 2023
Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting
6th June 2023
Carbios aims to be a leader in growing r-PET market with an ambition to capture 8 to 12% share by 2035 through licensing model
6th June 2023
Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expression
5th June 2023
Element Materials creates a new Lab Solutions division within Life Sciences, providing advanced equipment for laboratories
5th June 2023
Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in France
1st June 2023
Medigene AG: Medigene Announces Pipeline Expansion into Neoantigens with Programs Targeting Multiple KRAS Mutations and HLAs
1st June 2023
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
1st June 2023
Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients
1st June 2023
Carbios will receive grants totaling €54 million from French State via France 2030 and Grand-Est Region[1] to finance construction of world’s first PET biorecycling plant and accelerate R&D activities
31st May 2023
Mainz Biomed Expands Commercial Footprint into Poland
31st May 2023
Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials
31st May 2023
Destiny Pharma: Board Changes Dr Debra Barker Appointed Interim CEO
25th May 2023
ONWARD: Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury
25th May 2023
Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper
24th May 2023
Medigene AG: Medigene Expands Patent Portfolio for its End-to-End Platform
22nd May 2023
MIG Capital: MIG Capital strengthens its investment team with four new professionals
17th May 2023
LEON appoints Dr. Setu Kasera as Chief Scientific Officer
16th May 2023
Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
16th May 2023
Carbios recognized as a flagship start-up in French green innovation at the Choose France Summit
16th May 2023
ONWARD Reports Q1 Business Update and Year-To-Date Highlights
16th May 2023
ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury
15th May 2023
Rentschler Biopharma supports the Laupheim Planetarium with a donation of 25,000 Euros
15th May 2023
Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases
15th May 2023
Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
15th May 2023
InflaRx Reports First Quarter 2023 Financial and Operating Results and Provides Business Update
11th May 2023
VPM contributes to the successful licensure of the novel malaria vaccine R21/Matrix-MTM for first use in Ghana
10th May 2023
Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence in the German, Austrian and Swiss private equity markets
10th May 2023
